Glenmede Trust’s Wave Life Sciences WVE Stock Holding History

Glenmede Trust’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,241	Closed	-$321K	–	1583
2026 Q1	$321K	Buy	44,241 +1,509	+4%	+$19.7K	﹤0.01%	1130
2025 Q4	$726K	Buy	+42,732	New	+$434K	﹤0.01%	825
2025 Q1	$435K	Buy	53,792 +6,383	+13%	+$69.8K	﹤0.01%	956
2024 Q4	$586K	Buy	47,409 +8,334	+21%	+$111K	﹤0.01%	873
2024 Q3	$320K	Buy	39,075 +16,235	+71%	+$97K	﹤0.01%	1073
2024 Q2	$114K	Buy	+22,840	New	+$130K	﹤0.01%	1242

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Glenmede Trust's WVE Position: Q2 2026 in Review

Glenmede Trust sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 44,241 shares — an estimated $321K sold.

Glenmede Trust first reported a position in WVE in Q2 2024 and held it in 6 quarters. The position peaked at $726K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Glenmede Trust reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
Glenmede Trust sold 44,241 Wave Life Sciences shares in Q2 2026, an estimated $321K.
Glenmede Trust first reported a position in Wave Life Sciences in Q2 2024 and held it in 6 quarters.
Glenmede Trust's Wave Life Sciences position peaked at $726K in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.